ORION CORP NEW UNSP/ADR (ORINY) analyst actions
Rating and price-target actions on ORINY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ORINY overview →
1 measured ORINY analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE) | Press release | — | — |
Keep exploring
More ORINY: earnings → · SEC filings → · ORINY overview →